ACTRN12610000668000已完成不适用
A prospective, randomised, double blind, safety and efficacy study comparing light and deep general anaesthesia monitored with the Bispectral Index (BIS) or Spectral Entropy (SE) to investigate whether light anaesthesia is associated with lower postoperative mortality than deep anaesthesia in patients having major surgery
Dr Timothy Short0 个研究点目标入组 100 人开始时间: 2010年8月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 60 Years 至 o limit（—）
- 性别
- All
入选标准
- •Age 60 and over, American Society of Anesthesiologists (ASA) Score 3 or 4, major surgery lasting over 2 hours, expected to stay in hospital two or more nights post-operatively, general anaesthesia including with major regional block, anaesthesia duration expected to be over two hours.
排除标准
- •Unable to monitor processed Electroencephalography (EEG)(eg most neurosurgery), not expected to survive one year with or without surgery, unable to consent, eg: dementia, , major psychiatric illness, not expected to be contactable one year later, surgery with wake-up test
研究者
相似试验
已完成
3 期
The effect of parecoxib on post craniotomy analgesia.ACTRN12605000600640Department of Anaesthesia, St Vincent's Hospital Melbourne82
进行中（未招募）
1 期
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertensioprimary or secondary hypertensionMedDRA version: 20.0 Level: LLT Classification code 10036695 Term: Primary hypertension System Organ Class: 10047065 - Vascular disordersMedDRA version: 20.0 Level: PT Classification code 10039834 Term: Secondary hypertension System Organ Class: 10047065 - Vascular disordersEUCTR2014-000674-18-BGArbor Pharmaceuticals, LLC.260
进行中（未招募）
1 期
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertensioprimary or secondary hypertensionMedDRA version: 17.1Level: LLTClassification code 10036695Term: Primary hypertensionSystem Organ Class: 10047065 - Vascular disordersMedDRA version: 17.1Level: PTClassification code 10039834Term: Secondary hypertensionSystem Organ Class: 10047065 - Vascular disordersEUCTR2014-000674-18-ITArbor Pharmaceuticals, LLC.215
进行中（未招募）
1 期
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertensioprimary or secondary hypertensionMedDRA version: 18.1 Level: LLT Classification code 10036695 Term: Primary hypertension System Organ Class: 10047065 - Vascular disordersMedDRA version: 18.1 Level: PT Classification code 10039834 Term: Secondary hypertension System Organ Class: 10047065 - Vascular disordersEUCTR2014-000674-18-HUArbor Pharmaceuticals, LLC.260
撤回
不适用
A prospective randomised double-blind, double-dummy, placebo-controlled crossover study to determine whether Glucagon-like peptide-1 (GLP-1) stimulates or suppresses pancreatic exocrine function in health.Type 2 DiabetesACTRN12614000815662Dr Adam Deane15